CosmeTech, LLC in Memphis inspected by FDA on May 21, 2024

Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA - Official Website
Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA - Official Website
0Comments

The Food and Drug Administration carried out an inspection of CosmeTech, LLC, located in Memphis, on May 21, 2024. The review concentrated on the company’s colors and cosmetics technology operations, according to data posted on the FDA’s website.

The FDA’s final report concluded that CosmeTech, LLC is not required to implement any corrective measures regarding its management practices.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA - Official Website

Sweetbio, Inc. in Memphis inspected by FDA on July 24, 2024

The FDA conducted an inspection at Sweetbio, Inc. in Memphis on July 24, 2024, focusing on device compliance and post-market assurance for devices.

Robert M. Califf, M.D. Commissioner of Food and Drugs - FDA - Official Website

FDA inspection conducted Dec. 18, 2024, at Memphis VA Medical Center IRB in Memphis

On December 18, 2024, the FDA conducted a bioresearch monitoring inspection at the Memphis VA Medical Center IRB in Memphis, as reported on the FDA’s website.

Mark Raza Principal Deputy Chief Counsel - FDA - Official Website

FDA conducts inspection of Mark S. LeDoux, M.D. in Memphis on Sept. 30, 2024

According to FDA data, an inspection focused on bioresearch monitoring was conducted at Mark S. LeDoux, M.D. in Memphis on September 30, 2024.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Memphis Standard.